Wuhou District Hospital
Chengdu, Sichuan, 610041, China
NCT Number: NCT01763775
The clinical protocol of the clinical testing of this device:
1. Objective of the test: To verify the functions and efficiency of devices. 2. Test methods and procedures: Comparison Test. 3. Device Under Test (DUT): Transtek Body Fat Analyzer, Model: GBF-1251-B, BF-1255-B, BF-1256-B, and GBF-1257-B. 4. Comparison device: Transtek, Glass Body Fat Analyzer, GBF-950-D. 5. Study endpoints: DUT and the comparison device are substantial equivalence. 6. Statistical methodology used: Description of statistical methods.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chengdu, Sichuan, 610041, China
The aim of clinical test is to collect weight, body fat, total body water, bone mass, and muscle mass reading value which measured by DUT and reference device.
The subject database shall contain at least 25 male and 25 female subjects and all above 18 years old.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Measuring weight, total body water, body fat, muscle mass, and bone mass. Measure each participants by Transtek 125X (GBF-1251-B, BF-1255-B, BF-1256-B, GBF-1257-B).
Measuring weight, total body water, body fat, muscle mass, and bone mass. Measure each participants by Transtek 950D (GBF-950-D).
Time frame: 5 Day
Body Fat, Total Body Water, Muscle Mass, Bone Mass
Time frame: 5 Days
Body Weight
Leo Wang
Other
Verify the Functions and Efficiency of Transtek (Trade Mark) Body Fat Analyzer, GBF-1251-B, BF-1255-B, BF-1256-B, and GBF-1257-B
Acronym: BS-BT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01296048
Body Fat Disorder, Body Weight
Chengdu, Sichuan, China
View Trial DetailsNCT01440894
Body Fat Disorder, Body Weight
Zhongshan, Guangdong, China
View Trial DetailsNCT02345109
Body Fat Disorder, Body Weight
Chengdu, Sichuan, China
View Trial DetailsNCT07713394
Behavior, Body Weight
Erzurum, Turkey, Turkey (Türkiye)
View Trial Details